Cardinal Health (CAH) Q2 FY26 earnings call

Cardinal Health delivered a strong Q2 FY26, marked by double-digit profit growth across all five operating segments, driven by robust demand in Pharmaceutical and Specialty Solutions and significant contributions from Other Growth Businesses. The company raised its full-year EPS guidance, reflecting confidence in continued momentum and strategic execution, particularly in specialty expansion and core business optimization.